Detalles de la búsqueda
1.
Safety and immunogenicity of a ChAdOx1 vaccine against Rift Valley fever in UK adults: an open-label, non-randomised, first-in-human phase 1 clinical trial.
Lancet Infect Dis
; 23(8): 956-964, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37060917
2.
Safety and immunogenicity of a simian-adenovirus-vectored rabies vaccine: an open-label, non-randomised, dose-escalation, first-in-human, single-centre, phase 1 clinical trial.
Lancet Microbe
; 3(9): e663-e671, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35907430
3.
Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial.
EBioMedicine
; 85: 104298, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36229342
Resultados
1 -
3
de 3
1
Próxima >
>>